共 18 条
- [1] The PTEN/ PI3K/AKT signalling pathway in cancer,therapeutic implications. Carnero A,Blanco-Aparicio C,Renner O,et al. Current Cancer Drug Targets . 2008
- [2] PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. Ogino S,Nosho K,Kirkner GJ,et al. Journal of Clinical Oncology . 2009
- [7] PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations. Janku F,Wheler JJ,Westin SN,Moulder SL,Naing A,Tsimberidou AM,Fu S,Falchook GS,Hong DS,Garrido-Laguna I,Luthra R,Lee JJ,Lu KH,Kurzrock R. Journal of Clinical Oncology . 2012
- [8] Extra Views Oncogenic Mutations of PIK3CA in Human Cancers. Samuels, Y,Velculescu, V. E. Cell Cycle . 2004
- [9] PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events. Agell L,Hernandez S,Salido M, et al. Modern Pathology . 2011
- [10] Helical Domain and Kinase Domain Mutations in P110alpha of Phosphatidylinositol 3-Kinase Induce Gain of Function by Different Mechanisms. Zhao L,Vogt P K. Proceedings of the National Academy of Sciences of the United States of America . 2008